OliPass Corp
KOSDAQ:244460
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bergs Timber AB (publ)
STO:BRG B
|
SE |
|
Zhongtai Futures Co Ltd
HKEX:1461
|
CN |
|
Haci Omer Sabanci Holding AS
IST:SAHOL.E
|
TR |
OliPass Corp
Total Liabilities
OliPass Corp
Total Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
OliPass Corp
KOSDAQ:244460
|
Total Liabilities
₩15.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Total Liabilities
₩5.1T
|
CAGR 3-Years
43%
|
CAGR 5-Years
25%
|
CAGR 10-Years
17%
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Total Liabilities
₩7.2B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Liabilities
₩253.5B
|
CAGR 3-Years
38%
|
CAGR 5-Years
55%
|
CAGR 10-Years
77%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Total Liabilities
₩126.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
|
D
|
DND PharmaTech Inc
KOSDAQ:347850
|
Total Liabilities
₩27.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
OliPass Corp
Glance View
OliPass Corp. develops biological products. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2019-09-20. The firm principally manufactures and sells nonopioid analgesic, hyperlipidemia medicine, ocular angiogenesis inhibitor, duchenne dystrophy medicine, cancer immunotherapy medicine and other products. In addition, the Company researches, develops and sells functional cosmetics through the artificial gene platform technology.
See Also
What is OliPass Corp's Total Liabilities?
Total Liabilities
15.5B
KRW
Based on the financial report for Sep 30, 2025, OliPass Corp's Total Liabilities amounts to 15.5B KRW.
What is OliPass Corp's Total Liabilities growth rate?
Total Liabilities CAGR 5Y
-16%
Over the last year, the Total Liabilities growth was 25%. The average annual Total Liabilities growth rates for OliPass Corp have been 1% over the past three years , -16% over the past five years .
